In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

W hen it comes to Love, Death + Robots, one can always count on the anthology series to crank out episodes that are equal parts gorgeous, grotesque, and gut-wrenching. However, Se ...

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces ...

New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

These scents, now bottled by a new biotech perfume brand called Future Society, never touched the noses of anyone alive today ...

Conduit regains compliance with Bid Price and Equity RequirementsCDT will continue to be listed and traded on The Nasdaq Stock Market NAPLES, Fla. and CAMBRIDGE, United Kingdom, May 21, 2025 (GLOBE ...

Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), a dynamic, multi-asset clinical stage, life science company delivering an efficient model for compound development, announces ...

Conduit both acquires and funds the development of Phase 2-ready assets, building an integrated and advanced platform-driven approach powered by artificial intelligence (AI) and cybernetics ... from ...

Virtus BBC ETF fell 9.74% to $17.15; SPDR XBI ETF dropped 6.63% to $77.17 on Tuesday. William Blair says Moderna faces increased scrutiny with mRNA vaccines under new CBER leadership. Get Matt ...

Are you exploring artificial intelligence in the life sciences? This event will feature a dynamic 45-minute panel discussion with leading UNC-Chapel Hill faculty innovators who have founded companies ...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor.